Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Kelfred Holdings's Net Margin % or its related term are showing as below:
HKSE:01134'
s Net Margin % Range Over the Past 10 Years
Min: -4.77 Med: 1.16 Max: 13.9
Current: -3.02
HKSE:01134's Net Margin % is ranked worse than 57.79% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 2.2
vs HKSE:01134: -3.02
Kelfred Holdings (HKSE:01134) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Kelfred Holdings Net Margin % Related Terms
Kelfred Holdings Net Margin % Historical Data
* Premium members only.
The historical data trend for Kelfred Holdings's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01134 vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Kelfred Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kelfred Holdings Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kelfred Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where Kelfred Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kelfred Holdings (HKSE:01134) has a Net Margin % of -4.04% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Kelfred Holdings and its competitors. According to the industry distribution chart, Kelfred Holdings ranks #471 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 57.8%.
Is Kelfred Holdings' Net Margin % too high?
Kelfred Holdings' current Net Margin % is -4.04%. Based on the distribution chart, Kelfred Holdings ranks #471 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Kelfred Holdings has a GF Score™ of 45/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kelfred Holdings' Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Kelfred Holdings ranks #471 out of 815 companies for Net Margin %. This places Kelfred Holdings in the lower half of its industry. The industry median Net Margin % is 2.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.20, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Kelfred Holdings and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kelfred Holdings's current Net Margin % is -4.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelfred Holdings stock overvalued right now?
Based on GuruFocus' analysis, Kelfred Holdings (HKSE:01134) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$0.44, compared to a current price of HK$0.24 — trading 45% below its estimated fair value. The current Net Margin % is -4.04%. Kelfred Holdings' overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Kelfred Holdings (HKSE:01134), the current Net Margin % is -4.04% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kelfred Holdings (HKSE:01134) Overvalued in 2026?
Based on GuruFocus' analysis, Kelfred Holdings stock appears to be undervalued.
The current stock price of HK$0.24 is trading 45% below its estimated GF Value™ of HK$0.44.
GuruFocus considers Kelfred Holdings to be Significantly Undervalued.
Key valuation signals for HKSE:01134:
Net Margin %: -4.04%
GF Value™: HK$0.44 vs. price of HK$0.24 (45% below fair value)
No single metric tells the full story. See the HKSE:01134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kelfred Holdings Ltd is an investment holding company. The Company and its subsidiaries are principally engaged in the manufacturing and sales of eyewear products. It produces and sells a wide range of spectacle frames and sunglasses mainly through original design manufacturing (ODM) and original equipment manufacturing (OEM) business models. The group offers integrated and customised services, including product design and development, raw materials procurement, production, quality control, packaging, and delivery. The Group also offers (OBM) products under the brand name Miga. It operates in Italy, the United Kingdom, Hong Kong, the U.S., PRC, India, Spain, the Philippines, Japan, Australia, France, and other countries. It generates a majority of its revenue from the United Kingdom.
45GF Score
Get the complete analysis for HKSE:01134
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01134 has been successfully added to your 
